UnitedHealth Group Incorporated (UNH) Holdings Trimmed by Harris Associates L P

Harris Associates L P lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.0% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,644,572 shares of the healthcare conglomerate’s stock after selling 1,735 shares during the quarter. UnitedHealth Group accounts for 1.5% of Harris Associates L P’s portfolio, making the stock its 17th largest position. Harris Associates L P owned 0.48% of UnitedHealth Group worth $861,196,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Marshall Wace LLP grew its stake in UnitedHealth Group by 441.4% during the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after purchasing an additional 11,361 shares in the last quarter. American Century Companies Inc. lifted its holdings in UnitedHealth Group by 16.9% during the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after buying an additional 681,111 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in UnitedHealth Group by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after buying an additional 183,401 shares during the last quarter. Essex Financial Services Inc. lifted its holdings in UnitedHealth Group by 12.3% during the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after buying an additional 967 shares during the last quarter. Finally, Factory Mutual Insurance Co. lifted its holdings in UnitedHealth Group by 20.9% during the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after buying an additional 72,000 shares during the last quarter. Hedge funds and other institutional investors own 86.20% of the company’s stock.

In other news, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now directly owns 195,625 shares in the company, valued at approximately $38,755,268.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Michele J. Hooper sold 5,000 shares of UnitedHealth Group stock in a transaction on Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the transaction, the director now owns 36,989 shares in the company, valued at $8,218,955.80. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 62,606 shares of company stock worth $12,677,525. 0.89% of the stock is owned by insiders.

A number of research firms have commented on UNH. Raymond James Financial reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday. Cowen reaffirmed an “outperform” rating and set a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Wells Fargo & Company reaffirmed an “outperform” rating and set a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Piper Jaffray Companies increased their target price on UnitedHealth Group to $242.00 and gave the stock an “overweight” rating in a report on Wednesday, November 29th. Finally, Jefferies Group reaffirmed a “buy” rating and set a $248.00 target price on shares of UnitedHealth Group in a report on Friday, December 1st. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and an average target price of $224.56.

UnitedHealth Group Incorporated (UNH) traded down $0.15 on Thursday, reaching $219.94. The company had a trading volume of 2,397,400 shares, compared to its average volume of 3,116,121. UnitedHealth Group Incorporated has a 12-month low of $156.09 and a 12-month high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. The firm has a market cap of $213,282.06, a PE ratio of 22.93, a P/E/G ratio of 1.63 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same period last year, the firm earned $2.17 EPS. The firm’s revenue was up 8.7% compared to the same quarter last year. equities analysts predict that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 33.26%.

TRADEMARK VIOLATION WARNING: This story was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at https://www.chaffeybreeze.com/2017/12/07/unitedhealth-group-incorporated-unh-holdings-trimmed-by-harris-associates-l-p.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply